Kohjin Bio Co

Kohjin Bio Co ROA

The Return on Assets (ROA) of Kohjin Bio Co (177A.T) as of Nov 2, 2026 is 8.77 %. In the previous year, Return on Assets (ROA) was 5.84 % — a change of 50.04% (higher).

ROA

8.77 %

YoY

50.04%

Last updated:

In 2025, Kohjin Bio Co's return on assets (ROA) was 8.77 %, a 50.04% increase from the 5.84 % ROA in the previous year.

The Kohjin Bio Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2022
10.50 JPY
Jan 1, 2023
13.53 JPY
Jan 1, 2024
5.84 JPY
Jan 1, 2025
8.77 JPY
The Kohjin Bio Co ROA history
YEARROAYoY
8.77 %+50.04%
5.84 %-56.81%
13.53 %+28.78%
10.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Kohjin Bio Co Stock analysis

What does Kohjin Bio Co do? Kohjin Bio Co Ltd generates revenue through three business segments. The Tissue Culture segment sells serum-free media for regenerative medicine and immunotherapy research, targeting research institutions and biotech companies. The Microbiology segment offers pathogen testing media for clinical, food, and pharmaceutical quality control, purchased by hospitals, food producers, and cosmetics manufacturers. The Cell Processing segment provides contract cell processing services to medical institutions under the Regenerative Medicine Safety Act, with facilities approved for manufacturing specified cell products. Revenue comes from direct sales of media products and service contracts for cell processing operations. The company's products include bacterial testing media, in vitro diagnostic drugs, and cell culture media, all sold under its own brand. Medical institutions, research organizations, and quality control departments in food and pharmaceutical industries are the primary buyers. The Microbiology segment serves clinical laboratories and food safety testing facilities, while the Tissue Culture segment caters to regenerative medicine research centers. Cell Processing services are contracted by hospitals and clinics requiring specialized cell manufacturing under regulatory compliance. Kohjin Bio's business model relies on selling specialized media for laboratory and medical applications, with recurring revenue from long-term contracts in cell processing. The Microbiology segment's products are used in routine pathogen testing, ensuring steady demand from healthcare and food sectors. The Tissue Culture segment's serum-free media support emerging therapies, attracting biotech firms seeking advanced research tools. Cell Processing services are driven by Japan's expanding regenerative medicine market, where medical institutions outsource cell manufacturing to compliant facilities. Kohjin Bio Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding Kohjin Bio Co's Return on Assets (ROA)

Kohjin Bio Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Kohjin Bio Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Kohjin Bio Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Kohjin Bio Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Kohjin Bio Co stock

Return on Assets (ROA) of Kohjin Bio Co is 8.77 % in 2025.

Return on Assets (ROA) of Kohjin Bio Co changed from 5.84 % to 8.77 %, representing a 50.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Kohjin Bio Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Kohjin Bio Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Kohjin Bio Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Kohjin Bio Co